Myelodysplastic Syndromes Clinical Trials

1072 clinical trials for Myelodysplastic Syndromes across international registries, including 146 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms — RECRUITING · PHASE1
• eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation — RECRUITING · NA
• Pathogenesis of Hematologic Malignancies — RECRUITING
• Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT) — RECRUITING · NA
• Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia — RECRUITING · PHASE1
• Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation — RECRUITING · PHASE2
• Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances — RECRUITING · PHASE1
• A Study of TAK-226 for Anemia in Japanese Patients With Lower-Risk Myelodysplastic Syndromes — RECRUITING · PHASE2
• Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation — RECRUITING · PHASE3
• Mosaic Trial for Stem Cell Transplant Recipients — RECRUITING · NA
• A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring — RECRUITING · PHASE1
• A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose) — RECRUITING · PHASE2
• Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant — RECRUITING · NA
• Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS — RECRUITING
• Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies — RECRUITING
• Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS) — RECRUITING · PHASE2
• Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens — RECRUITING
• HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML — RECRUITING · PHASE1
• A Study of BGB-11417 in Participants With Myeloid Malignancies — RECRUITING · PHASE1
• CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT — RECRUITING · NA
• A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia. — RECRUITING · PHASE2
• Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome — RECRUITING · PHASE2
• Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants — RECRUITING
• Allo HSCT Using RIC and PTCy for Hematological Diseases — RECRUITING · PHASE2
• A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials — RECRUITING · PHASE3
• A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies — RECRUITING · PHASE1
• Registry of Older Patients With Cancer — RECRUITING
• Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS) — RECRUITING · PHASE2
• Biocollection in MyeloDysplastic Syndrome (P-MDS) — RECRUITING · NA
• Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT — RECRUITING · PHASE1
• Study to Evaluate the Safety and Tolerability of EP0042 — RECRUITING · PHASE1
• Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation — RECRUITING · PHASE1
• A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation — RECRUITING · PHASE1
• Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation — RECRUITING · PHASE1
• Investigation of the Genetics of Hematologic Diseases — RECRUITING
• Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation — RECRUITING · PHASE2
• A Phase II Study of Cladribine and Low Dose Cytarabine in Combination With Venetoclax, Alternating With Azacitidine and Venetoclax, in Patients With Higher-risk Myeloproliferative Chronic Myelomonocytic Leukemia or Higher-risk Myelodysplastic Syndromes With Excess Blasts — RECRUITING · PHASE2
• Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases — RECRUITING · PHASE2
• Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant — RECRUITING · PHASE1
• A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome — RECRUITING · PHASE2
• Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment — RECRUITING · PHASE1
• Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment — RECRUITING · PHASE1
• 5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies — RECRUITING · PHASE1
• Prognostic and predictive cytogenetic variants in hematological neoplasia — RECRUITING
• Cord Blood Transplantation in Children and Young Adults With Blood Cancer — RECRUITING · PHASE2
• A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions — RECRUITING · PHASE3
• Brain Cognitive Network Abnormalities in Anemia Patients Using fNIRS — RECRUITING
• Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS — RECRUITING · PHASE1
• Registry of the European Working Group (EWOG) of Myelodysplastic Syndrome (MDS) in children and adolescents — RECRUITING
• Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome — RECRUITING

Refine this search